Literature DB >> 11069230

Serum antibody as a marker of protection against natural rotavirus infection and disease.

F R Velázquez1, D O Matson, M L Guerrero, J Shults, J J Calva, A L Morrow, R I Glass, L K Pickering, G M Ruiz-Palacios.   

Abstract

To determine whether naturally acquired serum IgA and IgG antibodies were associated with protection against rotavirus infection and illness, a cohort of 200 Mexican infants was monitored weekly for rotavirus excretion and diarrhea from birth to age 2 years. Serum samples collected during the first week after birth and every 4 months were tested for anti-rotavirus IgA and IgG. Children with an IgA titer >1:800 had a lower risk of rotavirus infection (adjusted relative risk [aRR], 0.21; P<.001) and diarrhea (aRR, 0. 16; P=.01) and were protected completely against moderate-to-severe diarrhea. However, children with an IgG titer >1:6400 were protected against rotavirus infection (aRR, 0.51; P<.001) but not against rotavirus diarrhea. Protective antibody titers were achieved after 2 consecutive symptomatic or asymptomatic rotavirus infections. These findings indicate that serum anti-rotavirus antibody, especially IgA, was a marker of protection against rotavirus infection and moderate-to-severe diarrhea.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069230     DOI: 10.1086/317619

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  59 in total

1.  An age-structured epidemic model of rotavirus with vaccination.

Authors:  E Shim; Z Feng; M Martcheva; C Castillo-Chavez
Journal:  J Math Biol       Date:  2006-08-17       Impact factor: 2.259

2.  Genotypic characterization of rotaviruses and prevalence of serotype-specific serum antibodies in children in Kuwait.

Authors:  R W Marmash; A K Dalwai; G Szucs; A M Molla; A S Pacsa; W Al-Nakib; M J Albert
Journal:  Epidemiol Infect       Date:  2007-02-12       Impact factor: 2.451

3.  Human milk oligosaccharides shorten rotavirus-induced diarrhea and modulate piglet mucosal immunity and colonic microbiota.

Authors:  Min Li; Marcia H Monaco; Mei Wang; Sarah S Comstock; Theresa B Kuhlenschmidt; George C Fahey; Michael J Miller; Mark S Kuhlenschmidt; Sharon M Donovan
Journal:  ISME J       Date:  2014-02-13       Impact factor: 10.302

4.  Postvaccination Serum Antirotavirus Immunoglobulin A as a Correlate of Protection Against Rotavirus Gastroenteritis Across Settings.

Authors:  Julia M Baker; Jacqueline E Tate; Juan Leon; Michael J Haber; Virginia E Pitzer; Benjamin A Lopman
Journal:  J Infect Dis       Date:  2020-06-29       Impact factor: 5.226

5.  Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.

Authors:  Myron J Levin; Jane C Lindsey; Susan S Kaplan; Werner Schimana; Jody Lawrence; Monica M McNeal; Mutsa Bwakura-Dangarembizi; Anthony Ogwu; Evans M Mpabalwani; Paul Sato; George Siberry; Margaret Nelson; Darcy Hille; Geoffrey A Weinberg; Adriana Weinberg
Journal:  AIDS       Date:  2017-01-02       Impact factor: 4.177

6.  Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs.

Authors:  Lijuan Yuan; Ke Wen; Marli S P Azevedo; Ana M Gonzalez; Wei Zhang; Linda J Saif
Journal:  Vaccine       Date:  2008-04-18       Impact factor: 3.641

Review 7.  Rotavirus vaccines: an overview.

Authors:  Penelope H Dennehy
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4.

Authors:  Lijuan Yuan; Shinjiro Honma; Inyoung Kim; Albert Z Kapikian; Yasutaka Hoshino
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

9.  Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies.

Authors:  Joseph A Lewnard; Benjamin A Lopman; Umesh D Parashar; Naor Bar-Zeev; Prasanna Samuel; M Lourdes Guerrero; Guillermo M Ruiz-Palacios; Gagandeep Kang; Virginia E Pitzer
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

10.  Economic impact of a rotavirus vaccine in Brazil.

Authors:  Dagna O Constenla; Alexandre C Linhares; Richard D Rheingans; Lynn R Antil; Eliseu A Waldman; Luiz J da Silva
Journal:  J Health Popul Nutr       Date:  2008-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.